Important Safety Information | Prescribing Information







Key Resources for Eye Care Professionals



What the Experts Are Saying About LOTEMAX GEL


Bausch + Lomb is committed to providing resources that can help you incorporate
LOTEMAX GEL into your practice.

Please see Important Safety Information below.


 

Clinical Success with LOTEMAX GEL

LOTEMAX GEL can be used after a wide range of ocular surgery to treat
inflammation and pain—see what the experts are saying

  
    
 

Confidence with LOTEMAX GEL

Hear how your colleagues incorporate LOTEMAX GEL into their practice

 







 

Published Articles on LOTEMAX GEL

Read articles published by your colleagues about their clinical experience with LOTEMAX GEL.

Combining strategies in the counseling
and care of patients with cataracts


Clinical Considerations for Treatment
Selection for Ocular Inflammation and Pain
Following Cataract Surgery




 

Professional Resources

Tools for your patients’ post-operative experience.

Create customized medication regimen
instruction sheets for your patients


Purchase kits (cataract & refractive) to help
with your patients' post-operative care


 

 





Indication

LOTEMAX GEL (loteprednol etabonate ophthalmic gel) 0.5% is indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Important Safety Information

  • LOTEMAX GEL is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.
  • Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. If this product is used for 10 days or longer, IOP should be monitored.
  • Use of corticosteroids may result in posterior subcapsular cataract formation.
  • Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation and occurrence of perforations in those with diseases causing corneal and scleral thinning. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, and where appropriate, fluorescein staining.
  • Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infection. In acute purulent conditions, steroids may mask infection or enhance existing infections.
  • Use of corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and exacerbate the severity of many viral infections of the eye (including herpes simplex).
  • Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use.
  • Patients should not wear contact lenses when using LOTEMAX GEL.
  • The most common ocular adverse drug reactions were anterior chamber inflammation (5%), eye pain (2%) and foreign body sensation (2%).

Please click here for full Prescribing Information about LOTEMAX GEL.

LGX.0072.USA.17